The cancer drug tamoxifen: A potential therapeutic treatment for spinal cord injury

Journal of Neurotrauma

Volumn 31, Issue 3, 2014, Pages 268-283

  Guptarak, Jutatip ^a   Wiktorowicz, John E ^a   Sadygov, Rovshan G ^a   Zivadinovic, Dragoslava ^a   Paulucci Holthauzen, Adriana A ^a   Vergara, Leoncio ^b   Nesic, Olivera ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c Paul L Foster School of Medicine   (United States)

Author keywords

Aqp4; myelin; proteomics; spinal cord injury; tamoxifen

Indexed keywords

AQUAPORIN 4; MYELIN; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG SAFETY; GLIA; HISTOLOGY; MALE; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; THORACIC SPINAL CORD; UPREGULATION; WESTERN BLOTTING;

ANIMALS; AQUAPORIN 4; BLOTTING, WESTERN; BRAIN; FLUORESCENT ANTIBODY TECHNIQUE; MALE; NEUROPROTECTIVE AGENTS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TAMOXIFEN;

EID: 84893089402     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3108     Document Type: Article

References (73)

1. Amtul, Z., Wang, L., Westaway, D., and Rozmahel, R. F. (2010). Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 169, 781-786.
2. Bourque, M., Dluzen, D. E., and Di, Paolo T. (2009). Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol. 30, 142-157.
3. Garcia-Segura, L. M. and Melcangi, R. C. (2006). Steroids and glial cell function. Glia 54, 485-498.
4. Lebesgue, D., Chevaleyre, V., Zukin, R. S., and Etgen, A. M. (2009). Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids 74, 555-561.
5. Samantaray, S., Sribnick, E. A., Das, A., Thakore, N. P., Matzelle, D., Yu, S. P., Ray, S. K., Wei, L., and Banik, N. L. (2010). Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats. Ann. N. Y. Acad. Sci. 1199, 90-94.
6. Mhyre, A. J. and Dorsa, D. M. (2006). Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia. Neuroscience 138, 851-858.
7. Hosli, E., Jurasin, K., Ruhl, W., Luthy, R., and Hosli, L. (2001). Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system. Int. J. Dev. Neurosci. 19, 11-19.
8. Platania, P., Laureanti, F., Bellomo, M., Giuffrida, R., Giuffrida-Stella, A. M., Catania, M. V., and Sortino, M. A. (2003). Differential expression of estrogen receptors alpha and beta in the spinal cord during postnatal development: localization in glial cells. Neuroendocrinology 77, 334-340.
9. Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
10. Paige, L. A., Christensen, D. J., Gron, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C. Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., and Fowlkes, D. M. (1999). Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc. Natl. Acad. Sci. U. S. A. 96, 3999-4004.
11. Belandia, B. and Parker, M. G. (2003). Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114, 277-280.
12. Klinge, C. M. (2000). Estrogen receptor interaction with co-activators and co-repressors. Steroids 65, 227-251.
13. McKenna, N. J. and O'Malley, B. W. (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474.
14. Norris, J. D., Paige, L. A., Christensen, D. J., Chang, C. Y., Huacani, M. R., Fan, D., Hamilton, P. T., Fowlkes, D. M., and McDonnell, D. P. (1999). Peptide antagonists of the human estrogen receptor. Science 285, 744-746.
15. Marin-Husstege, M., Muggironi, M., Raban, D., Skoff, R. P., and Casaccia-Bonnefil, P. (2004). Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev. Neurosci. 26, 245-254.
16. Garcia-Segura, L. M., Cardona-Gomez, P., Naftolin, F., and Chowen, J. A. (1998). Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 9, 593-597.
17. de, Medina P., Favre, G., and Poirot, M. (2004). Multiple targeting by the antitumor drug tamoxifen: a structure-activity study. Curr. Med. Chem. Anticancer Agents 4, 491-508.
18. Amrollahi, Z., Rezaei, F., Salehi, B., Modabbernia, A. H., Maroufi, A., Esfandiari, G. R., Naderi, M., Ghebleh, F., Ahmadi-Abhari, S. A., Sadeghi, M., Tabrizi, M., and Akhondzadeh, S. (2011). Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J. Affect. Disord. 129, 327-331.
19. Mao, J., Yuan, J., Wang, L., Zhang, H., Jin, X., Zhu, J., Li, H., Xu, B., and Chen, L. (2013). Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current. J. Cell Physiol. 228, 991-1001.
20. Kimelberg, H. K. (2005). Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50, 389-397.
21. Arevalo, M. A., Diz-Chaves, Y., Santos-Galindo, M., Bellini, M. J., and Garcia-Segura, L. M. (2012). Selective oestrogen receptor modulators decrease the inflammatory response of glial cells. J. Neuroendocrinol. 24, 183-190.
22. Ismailog? lu, O., Oral, B., Görgülü , A., Sütcü , R., Demir, N. (2010). Neuroprotective effects of tamoxifen on experimental spinal cord injury in rats. J. Clin Neurosci. 17, 1306-1310.
23. Tian, D. S., Liu, J. L., Xie, M. J., Zhan, Y., Qu, W. S., Yu, Z. Y., Tang, Z. P., Pan, D. J., and Wang, W. (2009). Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats. J. Neurochem. 109, 1658-1667.
24. Durham-Lee, J. C., Wu, Y., Mokkapati, V. U., Paulucci-Holthauzen, A. A., and Nesic, O. (2012). Induction of angiopoietin-2 after spinal cord injury. Neuroscience 202, 454-464.
25. Kisanga, E. R., Gjerde, J., Schjott, J., Mellgren, G., and Lien, E. A. (2003) Tamoxifen administration and metabolism in nude mice and nude rats. J. Steroid Biochem. Mol. Biol. 84, 361-367.
26. Robins, H. I., Won, M., Seiferheld, W. F., Schultz, C. J., Choucair, A. K., Brachman, D. G., Demas, W. F., and Mehta, M. P. (2006). Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. Neuro. Oncol. 8, 47-52.
27. Greaves, P., Goonetilleke, R., Nunn, G., Topham, J., and Orton, T. (1993). Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res. 53, 3919-3924.
28. Basso, D. M., Beattie, M. S., and Bresnahan, J. C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
29. Pretzer, E. and Wiktorowicz, J. E. (2008). Saturation fluorescence labeling of proteins for proteomic analyses. Anal. Biochem. 374, 250-262.
30. Straub, C., Pazdrak, K., Young, T. W., Stafford, S. J., Wu, Z., Wiktorowicz, J. E., Haag, A. M., English, R. D., Soman, K. V., and Kurosky, A. (2009). Toward the Proteome of the Human Peripheral Blood Eosinophil. Proteomics. Clin. Appl. 3, 1151-1173.
31. Guptarak, J., Wanchoo, S., Durham-Lee, J., Wu, Y., Zivadinovic, D., Paulucci-Holthauzen, A., and Nesic, O. (2013). Inhibition of IL-6 signaling:Anovel therapeutic approach to treating spinal 3cord injury pain. Pain 154,1115-1128.
32. Papkoff, J., Rubinfeld, B., Schryver, B., and Polakis, P. (1996). Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell Biol. 16, 2128-2134.
33. McMahon, S. S. and McDermott, K. W. (2002). Morphology and differentiation of radial glia in the developing rat spinal cord. J. Comp Neurol. 454, 263-271.
34. Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 57, 289-300.
35. R Development Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria.
36. Fudge, M. A., Kavaliers, M., Baird, J. P., and Ossenkopp, K. P. (2009). Tamoxifen produces conditioned taste avoidance in male rats: an analysis of microstructural licking patterns and taste reactivity. Horm. Behav. 56, 322-331.
37. Gray, J. M., Schrock, S., and Bishop, M. (1993). Estrogens and antiestrogens: actions and interactions with fluphenazine on food intake and body weight in rats. Am. J. Physiol. 264, R1214-R1218.
38. Lopez, M., Lelliott, C. J., Tovar, S., Kimber, W., Gallego, R., Virtue, S., Blount, M., Vazquez, M. J., Finer, N., Powles, T. J., O'Rahilly, S., Saha, A. K., Dieguez, C., and Vidal-Puig, A. J. (2006). Tamoxifeninduced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55, 1327-1336.
39. Wade, G. N. and Heller, H. W. (1993). Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats. Am. J. Physiol 264, R1219-R1223.
40. Kasama-Yoshida, H., Tohyama, Y., Kurihara, T., Sakuma, M., Kojima, H., and Tamai, Y. (1997). A comparative study of 2¢,3¢-cyclic-nucleotide 3¢-phosphodiesterase in vertebrates: cDNA cloning and amino acid sequences for chicken and bullfrog enzymes. J. Neurochem. 69, 1335-1342.
41. Liu, A., Stadelmann, C., Moscarello, M., Bruck, W., Sobel, A., Mastronardi, F. G., and Casaccia-Bonnefil, P. (2005). Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders. J. Neurosci. 25, 737-747.
42. Nielsen, J. A., Maric, D., Lau, P., Barker, J. L., and Hudson, L. D. (2006). Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J. Neurosci. 26, 9881-9891.
43. Mondal, S., Dirks, P., and Rutka, J. T. (2010). Immunolocalization of fascin, an actin-bundling protein and glial fibrillary acidic protein in human astrocytoma cells. Brain Pathol. 20, 190-199.
44. Yamasaki, M., Yamada, K., Furuya, S., Mitoma, J., Hirabayashi, Y., and Watanabe, M. (2001). 3-Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain. J. Neurosci. 21, 7691-7704.
45. Berg, R. W., Chen, M. T., Huang, H. C., Hsiao, M. C., and Cheng, H. (2009). A method for unit recording in the lumbar spinal cord during locomotion of the conscious adult rat. J. Neurosci. Methods 182, 49-54.
46. Falgairolle, M., de, Seze M., Juvin, L., Morin, D., and Cazalets, J. R. (2006). Coordinated network functioning in the spinal cord: an evolutionary perspective. J. Physiol. Paris 100, 304-316.
47. Fuss, B., Mallon, B., Phan, T., Ohlemeyer, C., Kirchhoff, F., Nishiyama, A., and Macklin, W. B. (2000). Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev. Biol. 218, 259-274.
48. Nesic, O., Lee, J., Ye, Z., Unabia, G. C., Rafati, D., Hulsebosch, C. E., and Perez-Polo, J. R. (2006). Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience 143, 779-792.
49. Tator, C. H., Hashimoto, R., Raich, A., Norvell, D., Fehlings, M. G., Harrop, J. S., Guest, J., Aarabi, B., and Grossman, R. G. (2012). Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J. Neurosurg. Spine 17, 157-229.
50. Guest, J., Harrop, J. S., Aarabi, B., Grossman, R. G., Fawcett, J. W., Fehlings, M. G., and Tator, C. H. (2012). Optimization of the decision-making process for the selection of therapeutics to undergo clinical testing for spinal cord injury in the North American Clinical Trials Network. J. Neurosurg. Spine 17, 94-101.
51. O'Brian, C. A., Liskamp, R. M., Solomon, D. H., and Weinstein, I. B. (1985). Inhibition of protein kinase C by tamoxifen. Cancer Res. 45, 2462-2465.
52. O'Brian, C. A., Housey, G. M., and Weinstein, I. B. (1988). Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. Cancer Res. 48, 3626-3629.
53. Zarate, C. A., Jr., Singh, J. B., Carlson, P. J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D. A., and Manji, H. K. (2007). Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord. 9, 561-570.
54. Kisanga, E. R., Gjerde, J., Guerrieri-Gonzaga, A., Pigatto, F., Pesci-Feltri, A., Robertson, C., Serrano, D., Pelosi, G., Decensi, A., and Lien, E. A. (2004). Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clin. Cancer Res. 10, 2336-2343.
55. Lochab, S., Pal, P., Kanaujiya, J. K., Tripathi, S. B., Kapoor, I., Bhatt, M. L., Sanyal, S., Behre, G., and Trivedi, A. K. (2012). Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells. Proteomics 12, 1363-1377.
56. Durham-Lee, J. C., Mokkapati, V. U., Johnson, K. M., and Nesic, O. (2011). Amiloride improves locomotor recovery after spinal cord injury. J. Neurotrauma 28, 1319-1326.
57. Cao, Q., He, Q., Wang, Y., Cheng, X., Howard, R. M., Zhang, Y., DeVries, W. H., Shields, C. B., Magnuson, D. S., Xu, X. M., Kim, D. H., and Whittemore, S. R. (2010). Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J. Neurosci. 30, 2989-3001.
58. Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N., and Beattie, M. S. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76.
59. Liu, X. Z., Xu, X. M., Hu, R., Du, C., Zhang, S. X., McDonald, J. W., Dong, H. X., Wu, Y. J., Fan, G. S., Jacquin, M. F., Hsu, C. Y., and Choi, D. W. (1997). Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395-5406.
60. Shuman, S. L., Bresnahan, J. C., and Beattie, M. S. (1997). Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 50, 798-808.
61. Lee, J. Y., Choi, S. Y., Oh, T. H., and Yune, T. Y. (2012). 17beta-Estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting RhoA-JNK3 activation after spinal cord injury. Endocrinology 153, 3815-3827.
62. Li, Q. M., Tep, C., Yune, T. Y., Zhou, X. Z., Uchida, T., Lu, K. P., and Yoon, S. O. (2007). Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury. J. Neurosci. 27, 8395-8404.
63. Arevalo, M. A., Santos-Galindo, M., Lagunas, N., Azcoitia, I., and Garcia-Segura, L. M. (2011). Selective estrogen receptor modulators as brain therapeutic agents. J. Mol. Endocrinol. 46, R1-R9.
64. Cerciat, M., Unkila, M., Garcia-Segura, L. M., and Arevalo, M. A. (2010). Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 58, 93-102.
65. Suda, S., Segi-Nishida, E., Newton, S.S., Duman, R.S. (2008). A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation. Biol. Psychiatry 64, 311-319.
66. Rutkowsky, J.M., Wallace, B.K., Wise, P.M., O'Donnell, M.E. (2011). Effects of estradiol on ischemic factor-induced astrocyte swelling and AQP4 protein abundance. Am. J. Physiol. Cell Physiol. 301, C204-12.
67. Nesic, O., Guest, J. D., Zivadinovic, D., Narayana, P. A., Herrera, J. J., Grill, R. J., Mokkapati, V. U., Gelman, B. B., and Lee, J. (2010). Aquaporins in spinal cord injury: the janus face of aquaporin 4. Neuroscience 168, 1019-1035.
68. Kimura, A., Hsu, M., Seldin, M., Verkman, A. S., Scharfman, H. E., and Binder, D. K. (2010). Protective role of aquaporin-4 water channels after contusion spinal cord injury. Ann. Neurol. 67, 794-801.
69. Nielsen, S., Nagelhus, E. A., Amiry-Moghaddam, M., Bourque, C., Agre, P., and Ottersen, O. P. (1997). Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 17, 171-180.
70. Holen, T. (2011). The ultrastructure of lamellar stack astrocytes. Glia 59, 1075-1083.
71. Crane, J. M., Bennett, J. L., and Verkman, A. S. (2009). Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells. J. Biol. Chem. 284, 35850-35860.
72. Sorbo, J. G., Moe, S. E., Ottersen, O. P., and Holen, T. (2008). The molecular composition of square arrays. Biochemistry 47, 2631-2637.
73. Ratelade, J. and Verkman, A. S. (2012). Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int. J. Biochem. Cell Biol. 44, 1519-1530.